文献速递心血管CTDSA

高风险冠脉形态与生理属性作为药物与血运重建后结局标志物

High-Risk Morphological and Physiological Coronary Disease Attributes as Outcome Markers After Medical Treatment and Revascularization.
PubMed 文献 · JACC Cardiovasc Imaging · 2021-05-19

本研究纳入538例患者872支血管,用有创FFR与冠脉CTA评估高风险形态属性(HRAm)和生理属性(FFR≤0.8),随访5年主要复合终点。HRAm在FFR基础上提供增量预后价值,且HRAm数目越多事件风险越高;在1或2个HRAm的血管中PCI优于药物治疗,但≥2个HRAm时PCI的缺血缓解获益减弱。

要点

  • HRAm包括局部斑块负荷(MLA<4 mm²且斑块负荷≥70%)、不良斑块特征≥2、整体斑块负荷(TPV≥306.5 mm³且PAV≥32.2%)三类。
  • HRAm数目增加与5年复合终点风险升高相关(趋势P<0.001),且独立于FFR≤0.8。
  • FFR≤0.8血管中,PCI实现缺血缓解仅在0或1个HRAm时显著降低血管导向复合终点风险(HR 0.33,95%CI 0.12–0.93,P=0.035),≥2个HRAm时获益减弱。

关键影像表现/征象

  • HRAm包括局部斑块负荷(MLA<4 mm²且斑块负荷≥70%)、不良斑块特征≥2、整体斑块负荷(TPV≥306.5 mm³且PAV≥32.2%)。
  • 平均FFR为0.88±0.08,239支血管接受PCI,54支血管(6.2%)发生主要终点。

诊断标准与关键数值

  • 高风险生理属性定义为有创FFR≤0.8。
  • 高风险形态属性包括:局部斑块负荷(MLA<4 mm²且斑块负荷≥70%)、不良斑块特征≥2、整体斑块负荷(TPV≥306.5 mm³且PAV≥32.2%)。
  • 在1或2个HRAm的血管中,PCI组5年事件风险低于药物治疗组(9.7% vs. 14.7%),但0或≥3个HRAm时无此差异。
  • FFR≤0.8血管中,PCI实现缺血缓解(术前FFR≤0.8且术后FFR>0.8)在0或1个HRAm血管中较单纯药物治疗显著降低血管导向复合终点风险(HR 0.33,95%CI 0.12–0.93,P=0.035),≥2个HRAm时风险降低减弱。

临床应用与阅片要点

  • 在FFR基础上应关注CCTA所示高风险形态属性,以更全面评估预后风险。
  • 对1或2个HRAm且FFR≤0.8的血管,PCI可能优于单纯药物治疗;≥2个HRAm时需权衡PCI获益减弱。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: This study sought to evaluate the prognostic impact of plaque morphology and coronary physiology on outcomes after medical treatment or percutaneous coronary intervention (PCI).

BACKGROUND: Although fractional flow reserve (FFR) is currently best practice, morphological characteristics of coronary artery disease also contribute to outcomes.

METHODS: A total of 872 vessels in 538 patients were evaluated by invasive FFR and coronary computed tomography angiography. High-risk attributes (HRA) were defined as high-risk physiological attribute (invasive FFR ≤0.8) and high-risk morphological attributes including: 1) local plaque burden (minimum lumen area <4 mm2 and plaque burden ≥70%); 2) adverse plaque characteristics ≥2; and 3) global plaque burden (total plaque volume ≥306.5 mm3 and percent atheroma volume ≥32.2%). The primary outcome was the composite of revascularization, myocardial infarction, or cardiac death at 5 years.

RESULTS: The mean FFR was 0.88 ± 0.08, and PCI was performed in 239 vessels. The primary outcome occurred in 54 vessels (6.2%). All high-risk morphological attributes were associated with the increased risk of adverse outcomes after adjustment for FFR ≤0.8 and demonstrated direct prognostic effect not mediated by FFR ≤0.8. The 5-year event risk proportionally increased as the number of HRA increased (p for trend <0.001) with lower risk in the PCI group than the medical treatment group in vessels with 1 or 2 HRA (9.7% vs. 14.7%), but not in vessels with either 0 or ≥3 HRA. Of the vessels with pre-procedural FFR ≤0.8, ischemia relief by PCI (pre-PCI FFR ≤0.8 and post-PCI FFR >0.8) significantly reduced vessel-oriented composite outcome risk compared with medical treatment alone in vessels with 0 or 1 high-risk morphological attributes (hazard ratio: 0.33; 95% confidence interval: 0.12 to 0.93; p = 0.035), but the risk reduction was attenuated in vessels with ≥2 high-risk morphological attributes.

CONCLUSIONS: High-risk morphological attributes offered additive prognostic value to coronary physiology and may optimize selection of treatment strategies by adding to FFR-based risk predictions (CCTA-FFR Registry for Development of Comprehensive Risk Prediction Model; NCT04037163).

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Yang S, Koo BK, Hwang D, et al. High-Risk Morphological and Physiological Coronary Disease Attributes as Outcome Markers After Medical Treatment and Revascularization. JACC Cardiovasc Imaging. 2021. PMID: 34023270. doi:10.1016/j.jcmg.2021.04.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。